Chemical Formula: C12H17N5O4

Chemical Formula C12H17N5O4

Found 18 metabolite its formula value is C12H17N5O4

NSC627046

N6,N6-Dimethyladenosine

C12H17N5O4 (295.1280482)


N6,N6-Dimethyladenosine is a modified ribonucleoside previously found in rRNA, and also exhibits in mycobacterium bovis Bacille Calmette-Guérin tRNA[1].

   

N(6),O(2)-Dimethyladenosine

2-(hydroxymethyl)-4-methoxy-5-[6-(methylamino)-9H-purin-9-yl]oxolan-3-ol

C12H17N5O4 (295.1280482)


   

N2-Ethyl-2'-deoxyguanosine

2-(ethylamino)-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one

C12H17N5O4 (295.1280482)


   

6N-Me-2-Methyladenosine

6N-Me-2-Methyladenosine

C12H17N5O4 (295.1280482)


   

O6-Ethyl-deoxyguanosine

O6-Ethyl-deoxyguanosine

C12H17N5O4 (295.1280482)


   

1-Ethyl-deoxyguanosine

1-Ethyl-deoxyguanosine

C12H17N5O4 (295.1280482)


   

N2-Ethyl-deoxyguanosine

N2-Ethyl-deoxyguanosine

C12H17N5O4 (295.1280482)


   

1-Piperazineaceticacid, 4-methyl-, 2-[(5-nitro-2-furanyl)methylene]hydrazide

1-Piperazineaceticacid, 4-methyl-, 2-[(5-nitro-2-furanyl)methylene]hydrazide

C12H17N5O4 (295.1280482)


   

4,6-Di-morpholin-4-yl-[1,3,5]triazine-2-carboxylic acid

4,6-Di-morpholin-4-yl-[1,3,5]triazine-2-carboxylic acid

C12H17N5O4 (295.1280482)


   

Entecavir hydrate

Entecavir monohydrate

C12H17N5O4 (295.1280482)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent Entecavir monohydrate (BMS200475 monohydrate; SQ34676 monohydrate) is a potent and selective inhibitor of HBV, with an EC50 of 3.75 nM in HepG2 cell.

   

Sulodexide

Adenosine, N-methyl-2-O-methyl-

C12H17N5O4 (295.1280482)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AB - Heparin group D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D006401 - Hematologic Agents > D000925 - Anticoagulants D009676 - Noxae > D000963 - Antimetabolites D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents D007004 - Hypoglycemic Agents

   

2-Deoxy-N-ethylguanosine

2-Deoxy-N-ethylguanosine

C12H17N5O4 (295.1280482)


   

O(6)-Ethyl-2-deoxyguanosine

O(6)-Ethyl-2-deoxyguanosine

C12H17N5O4 (295.1280482)


   

N,N-Dimethyladenosine

N6,N6-Dimethyladenosine

C12H17N5O4 (295.1280482)


N6,N6-Dimethyladenosine is a modified ribonucleoside previously found in rRNA, and also exhibits in mycobacterium bovis Bacille Calmette-Guérin tRNA[1].

   

N(6),N(6)-Dimethyladenosine

N(6),N(6)-Dimethyladenosine

C12H17N5O4 (295.1280482)


   

N6,2′-O-Dimethyladenosine

N6,2′-O-Dimethyladenosine

C12H17N5O4 (295.1280482)


N6,2′-O-Dimethyladenosine, a substrate of fat mass and obesity-associated gene (FTO), is a reversible modification widely occurred on varied RNA molecules. N6,2′-O-Dimethyladenosine can regulate obesity[1][2].

   

N6-Ethyladenosine

N6-Ethyladenosine

C12H17N5O4 (295.1280482)


N6-Ethyladenosine is an adenosine derivative, acts as a Adenosine receptor agonist, with Kis of 4.9 and 4.7 nM for hA1AR and hA3AR, respectively[1]. N6-Ethyladenosine is an adenosine derivative, acts as a Adenosine receptor agonist, with Kis of 4.9 and 4.7 nM for hA1AR and hA3AR, respectively[1].

   

(2r,3r,5r)-5-{6-[(2-hydroxyethyl)amino]purin-9-yl}-2-(hydroxymethyl)oxolan-3-ol

(2r,3r,5r)-5-{6-[(2-hydroxyethyl)amino]purin-9-yl}-2-(hydroxymethyl)oxolan-3-ol

C12H17N5O4 (295.1280482)